ANALYSIS OF THE HUMAN CD21 TRANSCRIPTION UNIT REVEALS DIFFERENTIAL SPLICING OF EXON-11 IN MATURE TRANSCRIPTS AND EXCLUDES ALTERNATIVE SPLICING AS THE MECHANISM CAUSING SOLUBILIZATION OF CD21
H. Illges et al., ANALYSIS OF THE HUMAN CD21 TRANSCRIPTION UNIT REVEALS DIFFERENTIAL SPLICING OF EXON-11 IN MATURE TRANSCRIPTS AND EXCLUDES ALTERNATIVE SPLICING AS THE MECHANISM CAUSING SOLUBILIZATION OF CD21, Molecular immunology, 34(10), 1997, pp. 683-693
CD21 is found in a soluble form at low levels in normal human sera and
at elevated levels in sera from patients with EBV-associated diseases
and B-CLL. Ablation of complement, injection of recombinant soluble C
D21 and knock-out of CD21 in mice by gene targeting interfere with T-c
ell-dependent immune responses, suggesting that in vivo-generated solu
ble CD21 may exert immunoregulatory functions. Soluble CD21 has a mole
cular weight of 130 000/135 000, which is equivalent to the entire ext
racellular domain. Soluble forms of membrane-anchored molecules may be
generated by proteolytic cleavage of the extracellular portion or by
the exclusion of the hydrophobic transmembrane region via alternative
splicing. To delineate whether alternative splicing of CD21 mRNA creat
es transcripts encoding for the soluble form of CD21 we analyzed by PC
R CD21 expression in PBLs, spleen, tonsils, bone marrow and in various
cell lines. We found that all CD21 mRNA species contained the transme
mbrane exons, thus excluding alternative splicing as a factor contribu
ting to the serum pool of soluble CD21. Differential splicing of the C
D21 transcription unit has also been suggested for exon 11. Within the
CD21 gene exons 3, 7 and 11 have a high degree of homology. However,
we found in malignant human cell lines and primary lymphocytes from bl
ood, bone marrow, tonsils and spleen that exon 11, but not exon 3 or 7
, is subject to alternative splicing. We cloned and sequenced the intr
on preceding exon 11 and found that the surrounding splice sites match
consensus splice sites. In conclusion, we show that human CD21 exon 1
1 is alternatively spliced in malignant cell lines of lymphoid origin
and in purified lymphocytes from blood, tonsils, bone marrow and splee
n. We found that both exon 11 lacking and exon 11 containing transcrip
ts are always coexpressed and the ratio of of the two forms is > 1. Mo
reover, we exclude the possibility that alternative splicing of the tr
ansmembrane region is the mechanism leading to soluble CD21. (C) 1997
Elsevier Science Ltd. All rights reserved.